Blocking the PD-L1/PD-1 axis and TGFβ actions reduced TGFβ signalling in stromal cells, facilitated T-cell penetration into the centre of the tumour, and provoked vigorous antitumour immunity and tumour regression in mice. Here, CD274 is linked to neoplasm.